title: Development of immune hyperinnervation in NGF-transgenic mice.
abstract: Sympathetic innervation of lymphoid tissues is localized to specific tissue compartments, but little is known of the "factors" that are important in establishing this pattern during development. Numerous studies have shown interactions of nerve growth factor (NGF) with the immune system, which may include modulation of immune innervation. We previously have shown that NGF transgenic mice, which overexpress NGF in skin and not immune tissues, have a dramatic hyperinnervation of splenic marginal zone and peripheral lymph node medulla and capsule. The purpose of the current studies was to determine if the presence of elevated NGF would alter immune system development and the process of sympathetic ingrowth. The results show that the splenic innervation in NGF transgenics gradually diverged from controls during the first two postnatal weeks, with the greatest change occurring between postnatal days 13 and 16 when the splenic organization was reaching the adult pattern. In contrast, the peripheral lymph nodes were hyperinnervated at an earlier age. mesenteric lymph nodes never diverged from the normal pattern. NGF levels in transgenic spleen were much higher than controls at postnatal days 1 and 2, when little innervation was present, and declined as the tissue matured, possibly because of NGF uptake by the ingrowing sympathetic fibers. This suggests that immune tissues are capable of concentrating NGF, which in turn may modulate the level of innervation by the sympathetic nervous system.
authors.affiliation: Department of Anatomy and Neurobiology, University of Kentucky Medical Center, Lexington 40536-0084, USA.
authors.forename: S L
authors.initials: SL
authors.lastname: Carlson
authors.forename: S
authors.initials: S
authors.lastname: Johnson
authors.forename: M E
authors.initials: ME
authors.lastname: Parrish
authors.forename: W A
authors.initials: WA
authors.lastname: Cass
mesh_terms: D000818:Animals; D000831:Animals, Newborn / Q000254:growth & development; D007107:Immune System / Q000254:growth & development / Q000294:innervation*; D008198:Lymph Nodes / Q000254:growth & development / Q000294:innervation; D051379:Mice; D008822:Mice, Transgenic / Q000235:genetics*; D009414:Nerve Growth Factors / Q000235:genetics* / Q000378:metabolism; D009422:Nervous System Diseases / Q000235:genetics*; D009638:Norepinephrine / Q000378:metabolism; D013154:Spleen / Q000254:growth & development / Q000294:innervation / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000254:growth & development / Q000378:metabolism / Q000503:physiopathology*
chemical_list: D009414:Nerve Growth Factors; D009638:Norepinephrine